Making HPV vaccines efficient: Cost-effectiveness analysis and the economic assemblage of healthcare in Colombia

Resultado de la investigación: Contribución a RevistaArtículo

Resumen

Cost-effectiveness analysis (CEA) is a strategy of calculation whose main objective is to compare for making decisions about the best, the most efficient solution (costs vs. benefits) to a particular problem. Cost-effectiveness analysis not only provides a framework to compare healthcare interventions which in practice seem incommensurable; it also performs a set of assumptions regarding the nature of healthcare and the behaviour of individuals. This article analyses the role of CEA as a device to produce value in the introduction of HPV vaccines in Colombia. In the different institutional pathways and decision-making scenarios cost-effectiveness has been the key issue that justified the inclusions and the exclusions that such technology entails. Cost-effectiveness has justified the definition of girls as the population target and the exclusion of boys from risks and benefits of this technology. Moreover, cost-effectiveness analysis has been a key instrument in the sexualising and de-sexualising of cervical cancer and HPV vaccines through the rationalisation of economic benefit.
Idioma originalEnglish (US)
PublicaciónScience and Technology Studies
Volumen31
N.º2
EstadoPublished - 2017
Publicado de forma externa

Huella dactilar

Cost-effectiveness
Economics
Healthcare
Vaccine
Colombia
Assemblages
Exclusion
Decision Making
Inclusion
Boys
Pathway
Scenarios
Costs
Rationalization
Cervical Cancer

Citar esto

@article{32da5b85f6be4ed9b00043e18077062d,
title = "Making HPV vaccines efficient: Cost-effectiveness analysis and the economic assemblage of healthcare in Colombia",
abstract = "Cost-effectiveness analysis (CEA) is a strategy of calculation whose main objective is to compare for making decisions about the best, the most efficient solution (costs vs. benefits) to a particular problem. Cost-effectiveness analysis not only provides a framework to compare healthcare interventions which in practice seem incommensurable; it also performs a set of assumptions regarding the nature of healthcare and the behaviour of individuals. This article analyses the role of CEA as a device to produce value in the introduction of HPV vaccines in Colombia. In the different institutional pathways and decision-making scenarios cost-effectiveness has been the key issue that justified the inclusions and the exclusions that such technology entails. Cost-effectiveness has justified the definition of girls as the population target and the exclusion of boys from risks and benefits of this technology. Moreover, cost-effectiveness analysis has been a key instrument in the sexualising and de-sexualising of cervical cancer and HPV vaccines through the rationalisation of economic benefit.",
author = "{Maldonado Castaneda}, {Oscar Javier}",
year = "2017",
language = "English (US)",
volume = "31",
journal = "Science and Technology Studies",
issn = "2243-4690",
publisher = "The Finnish Society for Science and Technology Studies",
number = "2",

}

TY - JOUR

T1 - Making HPV vaccines efficient: Cost-effectiveness analysis and the economic assemblage of healthcare in Colombia

AU - Maldonado Castaneda, Oscar Javier

PY - 2017

Y1 - 2017

N2 - Cost-effectiveness analysis (CEA) is a strategy of calculation whose main objective is to compare for making decisions about the best, the most efficient solution (costs vs. benefits) to a particular problem. Cost-effectiveness analysis not only provides a framework to compare healthcare interventions which in practice seem incommensurable; it also performs a set of assumptions regarding the nature of healthcare and the behaviour of individuals. This article analyses the role of CEA as a device to produce value in the introduction of HPV vaccines in Colombia. In the different institutional pathways and decision-making scenarios cost-effectiveness has been the key issue that justified the inclusions and the exclusions that such technology entails. Cost-effectiveness has justified the definition of girls as the population target and the exclusion of boys from risks and benefits of this technology. Moreover, cost-effectiveness analysis has been a key instrument in the sexualising and de-sexualising of cervical cancer and HPV vaccines through the rationalisation of economic benefit.

AB - Cost-effectiveness analysis (CEA) is a strategy of calculation whose main objective is to compare for making decisions about the best, the most efficient solution (costs vs. benefits) to a particular problem. Cost-effectiveness analysis not only provides a framework to compare healthcare interventions which in practice seem incommensurable; it also performs a set of assumptions regarding the nature of healthcare and the behaviour of individuals. This article analyses the role of CEA as a device to produce value in the introduction of HPV vaccines in Colombia. In the different institutional pathways and decision-making scenarios cost-effectiveness has been the key issue that justified the inclusions and the exclusions that such technology entails. Cost-effectiveness has justified the definition of girls as the population target and the exclusion of boys from risks and benefits of this technology. Moreover, cost-effectiveness analysis has been a key instrument in the sexualising and de-sexualising of cervical cancer and HPV vaccines through the rationalisation of economic benefit.

UR - https://sciencetechnologystudies.journal.fi/article/view/55582

M3 - Article

VL - 31

JO - Science and Technology Studies

JF - Science and Technology Studies

SN - 2243-4690

IS - 2

ER -